Skip to main content

Table 5 Comparative analysis of pathological characteristics of EAOC and non-EAOC patients(n, %)

From: Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer

Characteristics

EAOC

Non-EAOC

P

74

100

FIGO stage

0.417

 I/II

51

63

 

 III/IV

23

37

 

Differentiation

0.932

 Low

18

21

 

 Middle

34

52

 

 High

22

27

 

Biomarker

 ER(+)

32

52

0.253

 PR(+)

24

45

0.094

 P53(+)

59

68

0.085

 P16(+)

41

54

0.854

 MMR(-)

19

37

0.114

 Ki67(%)

30.0 ± 18.0

30.8 ± 18.94

0.767

 Napsin A(+)

18

37

0.075

 HNF-1β(+)

15

31

0.113